CG
SURF

Cutler Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Cutler Group’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-700
Closed -$2K – 6502
2020
Q4 		$2K Buy
+700
New +$6.08K ﹤0.01% 4296

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Cutler Group's SURF Position: Q2 2022 in Review

Cutler Group sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2022, closing a stake of 1,200 shares — an estimated $2.49K sold.

Cutler Group first reported a position in SURF in Q4 2020 and held it in 3 quarters. The position peaked at $9K in Q4 2021. 84 funds tracked by Wall St. Rank hold SURF as of Q2 2022.

  • Cutler Group reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Cutler Group sold 1,200 Surface Oncology, Inc. Common Stock shares in Q2 2022, an estimated $2.49K.
  • Cutler Group first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Cutler Group's Surface Oncology, Inc. Common Stock position peaked at $9K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2022.

Based on Cutler Group's 13F filing for Q2 2022, filed 4 Aug 2022.